BIOLOGIC CHOICES AFTER FIRST-LINE ANTI-TUMOUR NECROSIS FACTOR FAILURE IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

被引：0
|
作者：
Richards, H. [1 ]
Baildam, E. [1 ]
McCann, L. J. [1 ]
Cleary, A. G. [1 ]
Beresford, M. W. [1 ]
Pain, C. E. [1 ]
机构：
[1] Alder Hey Childrens NHS Fdn Trust, Dept Rheumatol, Liverpool, Merseyside, England
来源：
RHEUMATOLOGY | 2014年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
21
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [41] Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor α therapy in rheumatoid arthritis
    Canete, J. D.
    Celis, R.
    Moll, C.
    Izquierdo, E.
    Marsal, S.
    Sanmarti, R.
    Palacin, A.
    Lora, D.
    de la Cruz, J.
    Pablos, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) : 751 - 756
  • [42] Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis
    Wijbrandts, C. A.
    van Leuven, S. I.
    Boom, H. D.
    Gerlag, D. M.
    Stroes, E. G. S.
    Kastelein, J. J. P.
    Tak, P. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (08) : 1316 - 1321
  • [43] Strategies after the failure of the first anti-tumor necrosis factor α agent in rheumatoid arthritis
    Papagoras, Charalampos
    Voulgari, Paraskevi V.
    Drosos, Alexandros A.
    AUTOIMMUNITY REVIEWS, 2010, 9 (08) : 574 - 582
  • [44] Change in Gait Deviation Index after anti-tumour necrosis factor-α treatment in individuals with rheumatoid arthritis: a pilot study
    Brostrom, E. W.
    Esbjornsson, A-C
    von Heideken, J.
    Larsson, P.
    Wretenberg, P.
    Iversen, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (05) : 356 - 361
  • [45] First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
    Beukelman, Timothy
    Tomlinson, George
    Nigrovic, Peter A.
    Dennos, Anne
    Del Gaizo, Vincent
    Jelinek, Marian
    Riordan, Mary Ellen
    Schanberg, Laura E.
    Mohan, Shalini
    Pfeifer, Erin
    Kimura, Yukiko
    PEDIATRIC RHEUMATOLOGY, 2022, 20 (01)
  • [46] First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
    Timothy Beukelman
    George Tomlinson
    Peter A. Nigrovic
    Anne Dennos
    Vincent Del Gaizo
    Marian Jelinek
    Mary Ellen Riordan
    Laura E. Schanberg
    Shalini Mohan
    Erin Pfeifer
    Yukiko Kimura
    Pediatric Rheumatology, 20
  • [47] Effect of first-line biologic initiation on glucocorticoid exposure in children hospitalized with new-onset systemic juvenile idiopathic arthritis: emulation of a pragmatic trial using observational data
    Rosemary G. Peterson
    Rui Xiao
    Hannah Katcoff
    Brian T. Fisher
    Pamela F. Weiss
    Pediatric Rheumatology, 19
  • [48] Effect of first-line biologic initiation on glucocorticoid exposure in children hospitalized with new-onset systemic juvenile idiopathic arthritis: emulation of a pragmatic trial using observational data
    Peterson, Rosemary G.
    Xiao, Rui
    Katcoff, Hannah
    Fisher, Brian T.
    Weiss, Pamela F.
    PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)
  • [49] Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-α therapy: a clinical practice observational study of patients who discontinued treatment
    Estíbaliz Iglesias
    Vicenç Torrente-Segarra
    Rosa Bou
    Silvia Ricart
    María Isabel González
    Judith Sánchez
    Joan Calzada
    Jordi Antón
    Rheumatology International, 2014, 34 : 1053 - 1057
  • [50] Risk of Cardiovascular Events in Rheumatoid Arthritis Patients Treated with Subsequent-Line Biologic Disease Modifying Antirheumatic Drugs After Switching From First-Line Anti-Tumor Necrosis Factor Agents
    Johnston, Stephen
    Turpcu, Adam
    Shi, Nianwen
    Moawad, Dalia
    Alexander, Kimberly
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S40 - S40
12345